Librela Release (Novel Arthritis Medication)

We are happy to announce the release of Librela. Librela is the first and only monthly monoclonal antibody injection to provide long-term control of arthritis in dogs Approved as safe and is metabolized and eliminated like naturally occurring antibodies Works differently than NSAIDs by reducing Nerve growth factor effects Leads to increased activity and improved … Read more

X